Fraxel gets clearance for fractional ablative resurfacing
Reliant Technologies has received FDA approval for its 510(k) submission for its Fraxel repair laser system for Fractional Deep Dermal Ablation (FDDA™) treatment. The system is used for treating wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions and vascular dyschromia. The Fraxel repair laser system already had clearance for ablation, coagulation and skin resurfacing.
- FDA clearance to Reliant Technologies’ new hand pieces
- Toronto Cosmetic Clinic launches new non-invasive skin procedures
- FDA clears Cynosure TriActive LaserDermology System
- Eleme Medical receives CE Mark for SmoothShapes®
